Back
Expedia Group Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
96
EXPE
Expedia Group
Last Price:
180.76
Seasonality Move:
7.02%
Buy
75
MIRM
Mirum Pharmaceuticals
Last Price:
41.98
Seasonality Move:
32.47%
Buy
96
Expedia Group (EXPE)
is a Buy
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $180.76. The Score for EXPE is 96, which is 92% above its historic median score of 50, and infers lower risk than normal.
- EXPE is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
75
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $42.00. The Score for MIRM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $180.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPE is experiencing selling pressure, which indicates risk of future bearish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $42.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing slight buying pressure.
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.55 | Buy |
| Relative Strength Index (14 RSI): | 79.25 | Buy |
| Chaikin Money Flow: | -3727208 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (150.95 - 166.47) | Buy |
| Bollinger Bands (100): | (124.96 - 153.06) | Buy |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 63.67 | Buy |
| Chaikin Money Flow: | 75051 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.64 - 40.54) | Buy |
| Bollinger Bands (100): | (36.44 - 42.04) | Buy |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 166.2 | Buy |
| 20-day SMA: | 160.53 | Buy |
| 50-day SMA: | 149.47 | Buy |
| 200-day SMA: | 134.76 | Buy |
| 8-day EMA: | 168.82 | Buy |
| 20-day EMA: | 161.76 | Buy |
| 50-day EMA: | 151.91 | Buy |
| 200-day EMA: | 136.2 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.42 | Buy |
| 20-day SMA: | 39.82 | Buy |
| 50-day SMA: | 39.98 | Buy |
| 200-day SMA: | 32.76 | Buy |
| 8-day EMA: | 40.7 | Buy |
| 20-day EMA: | 40.06 | Buy |
| 50-day EMA: | 39.64 | Buy |
| 200-day EMA: | 34.84 | Buy |
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.25 per share, and an increase next year of $2.27 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.71 per share, and an increase next year of $0.88 per share.
Expedia Group Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||